AR130984A1 - Compuestos novedosos - Google Patents
Compuestos novedososInfo
- Publication number
- AR130984A1 AR130984A1 ARP230102982A ARP230102982A AR130984A1 AR 130984 A1 AR130984 A1 AR 130984A1 AR P230102982 A ARP230102982 A AR P230102982A AR P230102982 A ARP230102982 A AR P230102982A AR 130984 A1 AR130984 A1 AR 130984A1
- Authority
- AR
- Argentina
- Prior art keywords
- novel compounds
- compounds
- novel
- methods
- general formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La invención se refiere a compuestos novedosos que tienen la fórmula general (1) en donde R¹, R², R³, R⁴ y R⁵ son como se describe en la presente, composición que incluye los compuestos y métodos para usar los compuestos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22206271 | 2022-11-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR130984A1 true AR130984A1 (es) | 2025-02-05 |
Family
ID=84330531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP230102982A AR130984A1 (es) | 2022-11-09 | 2023-11-07 | Compuestos novedosos |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP4615841A1 (es) |
| JP (1) | JP2025539252A (es) |
| KR (1) | KR20250103639A (es) |
| CN (1) | CN120187721A (es) |
| AR (1) | AR130984A1 (es) |
| AU (1) | AU2023376398A1 (es) |
| CA (1) | CA3268380A1 (es) |
| CL (1) | CL2025001372A1 (es) |
| CO (1) | CO2025005518A2 (es) |
| CR (1) | CR20250185A (es) |
| IL (1) | IL319011A (es) |
| MX (1) | MX2025004959A (es) |
| PE (1) | PE20251696A1 (es) |
| TW (1) | TW202434581A (es) |
| WO (1) | WO2024099992A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11618751B1 (en) | 2022-03-25 | 2023-04-04 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives |
| US11319319B1 (en) | 2021-04-07 | 2022-05-03 | Ventus Therapeutics U.S., Inc. | Compounds for inhibiting NLRP3 and uses thereof |
| US12331048B2 (en) | 2022-10-31 | 2025-06-17 | Ventus Therapeutics U.S., Inc. | Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors |
| JP2026509587A (ja) * | 2023-03-23 | 2026-03-19 | 成都▲ざ▼▲霊▼生物医▲薬▼科技有限公司 | トリアジン化合物およびその使用 |
| TW202545527A (zh) | 2024-01-16 | 2025-12-01 | 英商諾得瑟拉公司 | Nlrp3及glp-1a組合療法 |
| WO2025261430A1 (zh) * | 2024-06-21 | 2025-12-26 | 成都赜灵生物医药科技有限公司 | 苯并噻吩类氘代化合物及其用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR119731A1 (es) * | 2019-05-17 | 2022-01-05 | Novartis Ag | Inhibidores del inflamasoma nlrp3 |
| WO2021219784A1 (en) * | 2020-04-30 | 2021-11-04 | Janssen Pharmaceutica Nv | New triazinoindole compounds |
-
2023
- 2023-11-07 AU AU2023376398A patent/AU2023376398A1/en active Pending
- 2023-11-07 AR ARP230102982A patent/AR130984A1/es unknown
- 2023-11-07 CA CA3268380A patent/CA3268380A1/en active Pending
- 2023-11-07 WO PCT/EP2023/080895 patent/WO2024099992A1/en not_active Ceased
- 2023-11-07 KR KR1020257015007A patent/KR20250103639A/ko active Pending
- 2023-11-07 CN CN202380077717.3A patent/CN120187721A/zh active Pending
- 2023-11-07 PE PE2025000898A patent/PE20251696A1/es unknown
- 2023-11-07 CR CR20250185A patent/CR20250185A/es unknown
- 2023-11-07 JP JP2025526536A patent/JP2025539252A/ja active Pending
- 2023-11-07 EP EP23801748.7A patent/EP4615841A1/en active Pending
- 2023-11-07 IL IL319011A patent/IL319011A/en unknown
- 2023-11-08 TW TW112143026A patent/TW202434581A/zh unknown
-
2025
- 2025-04-29 MX MX2025004959A patent/MX2025004959A/es unknown
- 2025-04-30 CO CONC2025/0005518A patent/CO2025005518A2/es unknown
- 2025-05-08 CL CL2025001372A patent/CL2025001372A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL319011A (en) | 2025-04-01 |
| WO2024099992A1 (en) | 2024-05-16 |
| MX2025004959A (es) | 2025-06-02 |
| JP2025539252A (ja) | 2025-12-04 |
| PE20251696A1 (es) | 2025-07-02 |
| TW202434581A (zh) | 2024-09-01 |
| CO2025005518A2 (es) | 2025-05-19 |
| AU2023376398A1 (en) | 2025-02-13 |
| KR20250103639A (ko) | 2025-07-07 |
| CL2025001372A1 (es) | 2025-06-23 |
| CA3268380A1 (en) | 2024-05-16 |
| CR20250185A (es) | 2025-06-10 |
| CN120187721A (zh) | 2025-06-20 |
| EP4615841A1 (en) | 2025-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR131006A1 (es) | Compuestos novedosos | |
| AR123424A1 (es) | Nuevos compuestos heterocíclicos | |
| AR131278A1 (es) | Compuestos novedosos | |
| AR131282A1 (es) | Compuestos novedosos | |
| AR132340A1 (es) | Compuestos tricíclicos para el tratamiento de cáncer | |
| CL2023003154A1 (es) | Compuestos heterocíclicos | |
| CL2024004085A1 (es) | Compuestos macrocíclicos inhibidores de kras, uso para tratar cáncer. | |
| CL2021001330A1 (es) | Nuevos compuestos heterocíclicos | |
| AR132377A1 (es) | Compuestos novedosos | |
| CO2025001184A2 (es) | Compuestos macrocíclicos para el tratamiento de cáncer | |
| CL2023003312A1 (es) | Inhibidores de nlrp3 | |
| ECSP20044709A (es) | Inhibidores de sarcómero cardíaco | |
| AR116283A1 (es) | Inhibidores del sarcómero cardíaco | |
| CR20220116A (es) | Compuestos heterocíclicos | |
| CL2022000019A1 (es) | Nuevos compuestos heterocíclicos | |
| CL2025001372A1 (es) | Derivados de triazinona como inhibidores de nlrp3. | |
| AR132456A1 (es) | Compuestos novedosos | |
| AR132992A1 (es) | Agonistas de trem2 | |
| CO2025008956A2 (es) | Inhibidores de polq | |
| CL2025000126A1 (es) | Compuestos derivados de indolsulfonamida y uso para tratar pérdida de mielina. | |
| CO2025003256A2 (es) | Derivados novedosos deuterados de pirimidin-2-il sulfonamida | |
| CO2025002033A2 (es) | Derivados novedosos de indol sulfonamida 7 sustituidos | |
| CO2022012773A2 (es) | Moduladores de nampt | |
| AR133375A1 (es) | Compuestos novedosos | |
| AR131633A1 (es) | Derivados novedosos de pirimidinil sulfonamida |